These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2088280)

  • 41. In vivo investigation of a new 109Cd gamma-ray induced K-XRF bone lead measurement system.
    Nie H; Chettle D; Luo L; O'Meara J
    Phys Med Biol; 2006 Jan; 51(2):351-60. PubMed ID: 16394343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors influencing bone lead concentration in a suburban community assessed by noninvasive K x-ray fluorescence.
    Kosnett MJ; Becker CE; Osterloh JD; Kelly TJ; Pasta DJ
    JAMA; 1994 Jan; 271(3):197-203. PubMed ID: 8277545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. L-shell x-ray fluorescence measurements of lead in bone: theoretical considerations.
    Todd AC
    Phys Med Biol; 2002 Feb; 47(3):491-505. PubMed ID: 11848124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship of bone and blood lead to hypertension. The Normative Aging Study.
    Hu H; Aro A; Payton M; Korrick S; Sparrow D; Weiss ST; Rotnitzky A
    JAMA; 1996 Apr; 275(15):1171-6. PubMed ID: 8609684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chemical analyses by means of nuclear and radiation methods--applications to biology, medicine, pharmaceutical sciences, agriculture, science and engineering--. 2. Particle induced X-ray emission (PIXE) analysis].
    Chiba R
    Radioisotopes; 1985 Nov; 34(11):648-56. PubMed ID: 3834528
    [No Abstract]   [Full Text] [Related]  

  • 46. The reproducibility of 109Cd-based X-ray fluorescence measurements of bone lead.
    Gordon CL; Webber CE; Chettle DR
    Environ Health Perspect; 1994 Aug; 102(8):690-4. PubMed ID: 7895710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.
    Rosen JF; Markowitz ME; Bijur PE; Jenks ST; Wielopolski L; Kalef-Ezra JA; Slatkin DN
    Environ Health Perspect; 1991 Jun; 93():271-7. PubMed ID: 1773798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Possibility of using a low-energy proton beam for particle-induced X-ray emission microanalysis.
    el-Ghawi UM; Bahal BM; al-Arbi SK
    Radiat Res; 1992 Sep; 131(3):243-8. PubMed ID: 1332106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of lead in bone phantoms and arsenic in soft tissue phantoms using synchrotron radiation and a portable x-ray fluorescence system.
    Groskopf C; Bennett SR; Gherase MR; Fleming DEB
    Physiol Meas; 2017 Feb; 38(2):374-386. PubMed ID: 28134135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preliminary synchrotron analysis of lead in hair from a lead smelter worker.
    Martin RR; Kempson IM; Naftel SJ; Skinner WM
    Chemosphere; 2005 Mar; 58(10):1385-90. PubMed ID: 15686756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of bullet residue in bone using proton-induced X-ray emission (PIXE) analysis.
    Fischbeck HJ; Ryan SR; Snow CC
    J Forensic Sci; 1986 Jan; 31(1):79-85. PubMed ID: 3944579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tibia lead levels and methodological uncertainty in 12-year-old children.
    Todd AC; Buchanan R; Carroll S; Moshier EL; Popovac D; Slavkovich V; Graziano JH
    Environ Res; 2001 May; 86(1):60-5. PubMed ID: 11386742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Feasibility of noninvasive analysis of lead in the human tibia by soft x-ray fluorescence.
    Wielopolski L; Rosen JF; Slatkin DN; Vartsky D; Ellis KJ; Cohn SH
    Med Phys; 1983; 10(2):248-51. PubMed ID: 6865866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microdistribution of lead in bone: a new approach.
    Jones KW; Bockman RS; Bronner F
    Neurotoxicology; 1992; 13(4):835-41. PubMed ID: 1302309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variability in XRF-measured tibia lead levels.
    Todd AC; Carroll S; Godbold JH; Moshier EL; Khan FA
    Phys Med Biol; 2000 Dec; 45(12):3737-48. PubMed ID: 11131196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synchrotron X-ray fluorescence and trace metals in the cementum rings of human teeth.
    Martin RR; Naftel SJ; Nelson AJ; Feilen AB; Narvaez A
    J Environ Monit; 2004 Oct; 6(10):783-6. PubMed ID: 15480490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of K X-ray fluorescence for measuring lead burden in epidemiological studies: high and low lead burdens and measurement uncertainty.
    Hu H; Milder FL; Burger DE
    Environ Health Perspect; 1991 Aug; 94():107-10. PubMed ID: 1954919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of trace levels of therapeutic gallium in bone as mapped by synchrotron x-ray microscopy.
    Bockman RS; Repo MA; Warrell RP; Pounds JG; Schidlovsky G; Gordon BM; Jones KW
    Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4149-53. PubMed ID: 2349224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bone lead levels and language processing performance.
    Campbell TF; Needleman HL; Riess JA; Tobin MJ
    Dev Neuropsychol; 2000; 18(2):171-86. PubMed ID: 11280963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiation risk to the human conceptus from measurement of maternal tibial bone lead by L-line x-ray fluorescence.
    Kalef-Ezra JA; Slatkin DN; Rosen JF; Wielopolski L
    Health Phys; 1990 Feb; 58(2):217-8. PubMed ID: 2298579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.